Trimedyne (TMED) Short Interest Ratio & Short Volume

Short interest is the volume of Trimedyne shares that have been sold short but have not yet been covered or closed out. As of March 13th, traders have sold 300 shares of TMED short. Learn More on Trimedyne's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TMED shares currently have a short interest ratio of 1.0. Learn More on Trimedyne's short interest ratio.

Here is how the short interest of companies in the industry of "electromedical equipment" compare to Trimedyne: Medtronic plc (0.99%), Sonova Holding AG (0.00%), Masimo Co. (5.61%), Getinge AB (publ) (0.00%), Integer Holdings Co. (9.16%), Soleno Therapeutics, Inc. (12.65%), TransMedics Group, Inc. (28.13%), LivaNova PLC (3.03%), CONMED Co. (8.92%), BioLife Solutions, Inc. (8.44%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AbbVie Inc. ($6.51 billion), Charter Communications, Inc. ($4.96 billion), McKesson Co. ($4.86 billion), Microchip Technology Incorporated ($2.85 billion), The Charles Schwab Co. ($2.75 billion), Match Group, Inc. ($2.50 billion), International Flavors & Fragrances Inc. ($1.95 billion), Tiffany & Co. ($1.93 billion), Wayfair Inc. ($1.78 billion), and Hormel Foods Co. ($1.77 billion). View all of the most shorted stocks.

Short selling TMED is an investing strategy that aims to generate trading profit from Trimedyne as its price is falling. TMED shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Trimedyne occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TMED, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TMED, twice per month. The most recent reporting period available is March, 13 2020.